Abiomed, Inc. ABMD
381.02 +381.02
Day range unavailable
52-week range unavailable
- Market cap
- 17.18B
- Forward P/E
- 60.77
- Analysts
- Hold
- Earnings date
- Feb 2, 2023
2Y +21.27 (+5.91%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 351.42
- 200-day average
- 291.67
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (0m) 10 8 buy · 2 hold · 0 sell
- Strong buy5
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 2, 2023
Expected Feb 2, 2023. Consensus EPS estimate 0.00.
Financials — quick view
ABMD Revenue — quarterly 265.92M
ABMD Net income — quarterly 106.13M
ABMD EPS — quarterly 2.34
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 2, 2023 | Dec 1, 2022 | 1.03 | — | — | — |
| Nov 1, 2022 | Sep 1, 2022 | 1.05 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | 1.08 | — | — | — |
| Apr 28, 2022 | Mar 1, 2022 | 1.08 | — | — | — |
| Feb 3, 2022 | Dec 1, 2021 | 0.98 | — | — | — |
| Oct 28, 2021 | Sep 1, 2021 | 0.98 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 1, 2022 | Morgan Stanley | up | Underweight | Equal-Weight |
| Nov 1, 2022 | Deutsche Bank | down | Buy | Hold |
| Oct 31, 2022 | William Blair | down | Outperform | Market Perform |
| Oct 31, 2022 | Piper Sandler | down | Overweight | Neutral |
| Oct 12, 2022 | Mizuho | init | — | Buy |
| Oct 9, 2022 | Piper Sandler | main | — | Overweight |
News
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 
Earnings Scheduled For November 1, 2022 
Earnings Scheduled For August 4, 2022 
Earnings Scheduled For April 28, 2022 
Earnings Scheduled For October 28, 2021 
Stocks That Hit 52-Week Highs On Thursday - Stocks That Hit 52-Week Highs On Wednesday
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Wednesday
Your note
Sign in to keep a note on ABMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEGAN MARC A. | General Counsel | Sale | Nov 3, 2022 | 12,237 |
| GREENFIELD ANDREW J | Officer | Stock Award(Grant) | Dec 15, 2022 | 15,977 |
| MINOGUE MICHAEL R | Chief Executive Officer | Stock Award(Grant) | Dec 15, 2022 | 380,048 |
| PLANO MATTHEW T | Officer | Sale | Oct 31, 2022 | 10,270 |
| RIVET JEANNINE M. | Director | Stock Award(Grant) | Aug 9, 2022 | 9,966 |
| ROSE ERIC A | Director | Stock Award(Grant) | Aug 9, 2022 | 15,203 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 11.69% | 5,269,340 | 1.29B | Sep 29, 2022 |
| Blackrock Inc. | 10.11% | 4,560,483 | 1.12B | Sep 29, 2022 |
| Baillie Gifford and Company | 8.04% | 3,624,937 | 890.50M | Sep 29, 2022 |
| State Street Corporation | 4.59% | 2,071,180 | 508.81M | Sep 29, 2022 |
| Primecap Management Company | 3.34% | 1,506,272 | 370.03M | Sep 29, 2022 |
| Wellington Management Group, LLP | 3.22% | 1,453,669 | 357.11M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.00% | 1,354,236 | 332.68M | Sep 29, 2022 |
| Vanguard U.S. Growth Fund | 2.70% | 1,216,666 | 315.46M | Aug 30, 2022 |
| Vanguard Mid-Cap Index Fund | 2.33% | 1,049,159 | 257.74M | Sep 29, 2022 |
| Vanguard 500 Index Fund | 2.29% | 1,030,404 | 253.13M | Sep 29, 2022 |
| Mainstay Winslow Large Cap Growth Fund | 1.71% | 769,500 | 225.47M | Jul 30, 2022 |
| Primecap Odyssey Aggressive Growth Fund | 1.68% | 758,623 | 186.36M | Sep 29, 2022 |